Finance

Beta
Lists
TEAM:NASDAQ
Atlassian Corp
$78.74
+5.44%
(+4.06) 1D
$78.72
-0.03% (-0.020)
After hours
Closed: Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TEAM...
Open
$75.30
High
$80.15
Low
$74.41
Mkt. cap
19.98B
Avg. vol.
5.54M
Volume
7.94M
52-wk high
$222.59
52-wk low
$56.01
EPS
-$0.83
Beta
1.07
Shares outstanding
159.63M
No. of employees
14K
Open
$75.30
High
$80.15
Low
$74.41
Mkt. cap
19.98B
Avg. vol.
5.54M
Volume
7.94M
52-wk high
$222.59
52-wk low
$56.01
EPS
-$0.83
Beta
1.07
Shares outstanding
159.63M
No. of employees
14K
News stories
From sources across the web
Profile
Atlassian Corporation is an international proprietary software company that specialises in collaboration tools designed primarily for software development and project management. Atlassian was founded in Sydney, Australia in 2002 and domiciled in the United States since 2022 as a pure holding company of Atlassian Corporation Plc. The company is globally headquartered in Sydney, with US headquarters in San Francisco, and over 12,000 employees across 14 countries. Atlassian currently serves over 300,000 customers in over 200 countries and territories around the world. Wikipedia
About Atlassian Corp
CEOMike Cannon-Brookes
Employees13.8K
Founded2002
Headquarters-
SectorApplication software
Analyst ratings
Based on 22 analysts giving stock ratings to TEAM in the past 3 months
Strong buy
Buy
19
Hold
3
Sell
0
12-month forecast
Based on 22 Wall Street analysts offering 12 month price targets for TEAM in the last 3 months.
Highest
Current $78.74
$295.00 (+274.65%)
Average
$129.71 (+64.73%)
Lowest
$95.00 (+20.65%)
Analyst
Recommendation
Action
Price target
Projected
Date
Keith Bachman
BMO Capital
Buy
Maintained
$95.00
+20.7%
06/25/2026
Ryan MacWilliams
Wells Fargo
Buy
Reiterated
$140.00
+77.8%
06/09/2026
Koji Ikeda
Bank of America Securities
Hold
Maintained
$110.00
+39.7%
06/08/2026
Miller Jump
Truist Financial
Buy
Reiterated
$100.00
+27%
05/15/2026
Ittai Kidron
Oppenheimer
Buy
Reiterated
$110.00
+39.7%
05/11/2026
Fatima Boolani
Citi
Buy
Reiterated
$110.00
+39.7%
05/07/2026
Gregg Moskowitz
Mizuho Securities
Buy
Maintained
$145.00
+84.2%
05/07/2026
David Hynes
Canaccord Genuity
Buy
Maintained
$150.00
+90.5%
05/06/2026
Keith Weiss
Morgan Stanley
Buy
Maintained
$120.00
+52.4%
05/07/2026
Arjun Bhatia
William Blair
Buy
Reiterated
-
-
05/07/2026
Derrick Wood
TD Cowen
Hold
Maintained
$105.00
+33.4%
05/07/2026
Allan Verkhovski
BTIG
Buy
Maintained
$130.00
+65.1%
05/07/2026
Rob Owens
Piper Sandler
Buy
Reiterated
$175.00
+122.3%
05/07/2026
Raimo Lenschow
Barclays
Buy
Reiterated
$112.00
+42.2%
05/07/2026
Robert Oliver
Robert W. Baird
Buy
Maintained
$120.00
+52.4%
05/01/2026
Thomas Blakey
Cantor Fitzgerald
Buy
Maintained
$107.00
+35.9%
05/01/2026
Adam Tindle
Raymond James
Buy
Maintained
$130.00
+65.1%
05/01/2026
Peter Weed
Bernstein
Buy
Maintained
$295.00
+274.7%
05/01/2026
Karl Keirstead
UBS
Hold
Maintained
$95.00
+20.7%
05/01/2026
Jason Celino
KeyBanc
Buy
Maintained
$130.00
+65.1%
05/01/2026
Andrew Sherman
TD Cowen
Hold
Maintained
$105.00
+33.4%
05/01/2026
Unknown Analyst
Macquarie
Buy
Maintained
$130.00
+65.1%
05/01/2026
Howard Ma
Guggenheim
Buy
Maintained
$115.00
+46.1%
04/16/2026
Brent Thill
Jefferies
Buy
Maintained
$150.00
+90.5%
02/06/2026
Last report
Apr 30, 2026
Fiscal period
Q3 2026
EPS / Est. (USD)
$1.75 / $1.34
+30.99%beat
Revenue / Est. (USD)
1.79B / 1.70B
+5.24%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.38B
1.43B
1.59B
1.79B
Cost of goods sold
234.42M
226.33M
237.69M
241.73M
Cost of revenue
234.42M
226.33M
237.69M
241.73M
Research and development expenses
700.68M
743.89M
826.49M
798.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
477.72M
502.99M
569.88M
579.26M
Operating expense
1.18B
1.25B
1.40B
1.38B
Total operating expenses
1.41B
1.47B
1.63B
1.62B
Operating income
-28.48M
-40.66M
-47.75M
167.55M
Other non operating income
10.90M
-5.92M
-13.55M
-4.92M
EBT including unusual items
-14.19M
-56.32M
-55.76M
-62.79M
EBT excluding unusual items
-15.75M
-25.38M
-55.76M
161.04M
Income tax expense
9.71M
-4.45M
-13.11M
35.60M
Effective tax rate
-68.40%
7.91%
23.52%
-56.69%
Other operating expenses
-
-
-
-
Net income
-23.90M
-51.87M
-42.64M
-98.39M
Net profit margin
-1.73%
-3.62%
-2.69%
-5.51%
Earnings per share
0.98
1.04
1.22
1.75
Interest and investment income
30.41M
29.84M
18.06M
12.55M
Interest expense
-8.14M
-8.64M
-12.52M
-14.14M
Net interest expenses
22.27M
21.21M
5.54M
-1.59M
Depreciation and amortization charges
-
-
-
-
EBITDA
-5.26M
-16.33M
-12.13M
208.83M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
Give me an overview of TEAM
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more